Kester, Maartje I <br/><br/>
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.  [electronic resource] 

 -  Neurobiology of aging  Aug 2011 
 - 1372-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-1497 
<br/><br/><label>Standard No.: </label>10.1016/j.neurobiolaging.2009.08.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Apolipoprotein E4--genetics<br/>Cognitive Dysfunction--cerebrospinal fluid<br/>Disease Progression<br/>Female<br/>Genetic Carrier Screening<br/>Genotype<br/>Homozygote<br/>Humans<br/>Male<br/>Middle Aged<br/>Peptide Fragments--cerebrospinal fluid<br/>Predictive Value of Tests<br/>Severity of Illness Index